SKIVE BIOGAS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.3% 0.3% 0.3% 0.3% 0.3%  
Bankruptcy risk  1.6% 2.1% 1.7% 0.7% 2.1%  
Credit score (0-100)  76 67 71 95 66  
Credit rating  A BBB A AA A  
Credit limit (kDKK)  3.3 0.0 0.8 395.5 0.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  1,461 1,238 1,420 3,335 857  
EBITDA  1,069 849 1,039 2,900 838  
EBIT  763 437 384 2,149 89.7  
Pre-tax profit (PTP)  694.6 307.5 163.3 1,887.0 -141.0  
Net earnings  540.4 239.5 207.7 1,500.8 -88.2  
Pre-tax profit without non-rec. items  695 307 163 1,887 -141  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  3,183 9,219 9,514 9,084 8,342  
Shareholders equity total  766 505 713 2,214 626  
Interest-bearing liabilities  0.0 1,030 720 7,405 7,320  
Balance sheet total (assets)  4,791 11,799 10,948 11,549 9,746  

Net Debt  -349 1,030 720 6,535 7,320  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,461 1,238 1,420 3,335 857  
Gross profit growth  16.0% -15.2% 14.7% 134.9% -74.3%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,791 11,799 10,948 11,549 9,746  
Balance sheet change%  6.2% 146.3% -7.2% 5.5% -15.6%  
Added value  1,068.7 849.1 1,039.4 2,804.8 838.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -589 5,624 -361 -1,180 -1,491  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  52.2% 35.3% 27.0% 64.4% 10.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  16.4% 5.3% 3.4% 19.1% 0.8%  
ROI %  45.5% 26.8% 19.4% 34.7% 0.9%  
ROE %  77.7% 37.7% 34.1% 102.6% -6.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  16.0% 4.3% 6.5% 19.2% 6.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -32.7% 121.3% 69.3% 225.4% 873.4%  
Gearing %  0.0% 203.9% 101.0% 334.5% 1,170.1%  
Net interest  0 0 0 0 0  
Financing costs %  12.6% 25.1% 25.2% 6.5% 3.1%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.4 0.2 0.1 0.3 0.2  
Current Ratio  0.4 0.2 0.1 0.3 0.2  
Cash and cash equivalent  349.4 0.0 0.0 869.9 0.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,970.8 -8,199.4 -8,330.6 -6,014.2 -6,912.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  1,069 849 1,039 2,805 838  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1,069 849 1,039 2,900 838  
EBIT / employee  763 437 384 2,149 90  
Net earnings / employee  540 240 208 1,501 -88